Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1214717 BOSTON, MA
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$41,942,256
+$11,210,302 QoQ
Shares Held
2,335,315
+5.6% QoQ
Ownership
2.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 207 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. AMLX ranks #17 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 13,289,622 $954,992,236
2 UTHR
UNITED THERAPEUTICS Corp
 996,598 $539,986,694
3 VTRS
Viatris Inc
 32,807,906 $520,989,547
4 TEVA
Teva Pharmaceutical Industries Ltd
 11,607,196 $393,251,799
5 NBIX
Neurocrine Biosciences Inc
 2,138,777 $360,469,474
6 ELAN
Elanco Animal Health Inc
 11,302,057 $278,143,622
7 ALKS
Alkermes plc.
 4,477,876 $234,640,702
8 LNTH
Lantheus Holdings, Inc.
 1,841,367 $204,281,254

All Filings in AMLX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,942,256 2,335,315
2026-03-31 $30,731,954 2,210,932
2025-12-31 $26,159,650 2,165,534
2025-09-30 $24,625,609 1,812,039
2025-06-30 $10,848,366 1,692,413
2025-03-31 $2,853,809 806,161
2024-12-31 $2,146,672 567,903
2024-09-30 $1,785,366 551,039
2024-06-30 $890,844 468,866
2024-03-31 $3,028,135 1,066,245
2023-12-31 $15,172,139 1,030,716
2023-09-30 $17,981,665 982,068
2023-06-30 $20,232,595 937,997
2023-03-31 $26,141,411 890,982
2022-12-31 $31,552,085 853,913
2022-09-30 $17,890,901 635,556
2022-06-30 $4,457,091 231,417
2022-03-31 $2,443,427 190,150